Finance

Lists
Portfolios
Track your investments in one place, get AI insights, and more
Top movers in your lists
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXV
Health care
SIXV
Health care
SIXV
+2.79%
1,761.39
+47.89
+2.79%
1,713.501,738.091,782.961,738.09
SIXB
Materials
SIXB
Materials
SIXB
+1.96%
1,120.04
+21.49
+1.96%
1,098.551,102.591,127.531,102.59
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.73%
2,391.92
+40.60
+1.73%
2,351.322,360.162,405.742,360.16
SIXR
Staples
SIXR
Staples
SIXR
+1.21%
873.77
+10.44
+1.21%
863.33865.66879.45865.35
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
583.20
+6.14
+1.06%
577.06577.06585.89576.02
US market summary
Major U.S. stock indexes advanced in early trading, snapping a three-day consecutive slide driven by technology sector volatility. The standard market benchmarks, including the Dow Jones Industrial Average and the S&P 500, recorded notable gains as broader investor appetite stabilized following policy adjustments.
Dive deeper with AI
Bond Yields Retract From Multi-Decade Highs After Treasury Policy Shift
Longer-term government bond yields experienced a sharp downward correction after surging to their highest levels since 2007. The sudden relief came after the U.S. Treasury announced an unexpected plan to at least double its debt buyback programs to inject crucial liquidity support into the capital markets.
Dive deeper with AI
Geopolitical Developments Stabilize Regional Commerce Postponements
Cross-border market anxieties eased following the decision to suspend planned tariffs that were initially scheduled to go into effect at midnight. This administrative delay contributed to positive momentum across index benchmarks and curbed immediate trade war worries.
Dive deeper with AI
Moderna Shares Skyrocket Following Promising Cancer Vaccine Results
Shares of biotech pioneer Moderna surged dramatically, more than doubling in value during early trading sessions. The massive upward move was fueled by successful late-stage clinical trial data for a personalized melanoma vaccine developed in tandem with pharmaceutical giant Merck.
Dive deeper with AI
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps